Evidence map›Paper›PMID 33806642›Full record

ArticleInternational journal of environmental research and public health2021

Altitude and SARS-CoV-2 Infection in the First Pandemic Wave in Spain.

Jesús Castilla, Ujué Fresán, Camino Trobajo-Sanmartín, Marcela Guevara

Open access · goldAbstract read
In one paragraph

Article in International journal of environmental research and public health, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
0.5field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 8 citations in OpenAlex.

  1. Seroprevalence of SARS-CoV-2 Antibodies in Africa: A Systematic Review and Meta-Analysis.International journal of environmental research and public health · 2022
    Pooled it
  2. Article
  3. Article
  4. Article
  5. SARS-CoV-2 Viral Load Analysis at Low and High Altitude: A Case Study from Ecuador.International journal of environmental research and public health · 2022
    Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Jesús CastillaInstituto de Salud Pública de Navarra, 31003 Pamplona, Spain.ORCID 0000-0002-6396-7265
Ujué FresánInstituto de Salud Pública de Navarra, 31003 Pamplona, Spain.ORCID 0000-0001-8140-4338
Camino Trobajo-SanmartínNavarre Institute for Health Research (IdiSNA), 31008 Pamplona, Spain.ORCID 0000-0001-5105-252X
Marcela GuevaraInstituto de Salud Pública de Navarra, 31003 Pamplona, Spain.ORCID 0000-0001-9242-6364
Instituto de Salud Pública de Navarra · ESComplejo Hospitalario de Navarra · ES

Funding

Horizon 2020 Framework Programme 101003673Instituto de Salud Carlos III COV20/00542Instituto de Salud Carlos III INT19/00028
6 · The paper itself

Abstract

After the first pandemic wave, a nationwide survey assessed the seroprevalence of SARS-CoV-2 antibodies in Spain and found notable differences among provinces whose causes remained unclear. This ecological study aimed to analyze the association between environmental and demographic factors and SARS-CoV-2 infection by province. The seroprevalence of SARS-CoV-2 antibodies by province was obtained from a nationwide representative survey performed in June 2020, after the first pandemic wave in Spain. Linear regression was used in the analysis. The seroprevalence of SARS-CoV-2 antibodies of the 50 provinces ranged from 0.2% to 13.6%. The altitude, which ranged from 5 to 1131 m, explained nearly half of differences in seroprevalence (

Indexed as

COVID-19SARS-CoV-2AltitudeAntibodies, ViralHumansImmunoglobulin GPandemicsSeroepidemiologic StudiesSpainAntibodies, ViralImmunoglobulin GaltitudeCOVID-19infection transmissionpopulation densitySARS-CoV-2seroepidemiological studies

Identifiers

PMID33806642
PMCPMC7967395
OpenAlexW3134947024

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.